Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

3.4K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

3.6K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Acceptability of an eHealth-Based Physical Activity Coaching Intervention During Pulmonary Rehabilitation for People With Chronic Obstructive Pulmonary Disease: Mixed Methods Study.

JMIR formative research·2026
Same author

Mechanical Load-Capacity Models for Bone in Youth - Analysis of Risk Signatures.

Journal of musculoskeletal & neuronal interactions·2026
Same author

Physical behaviour profiles and their associations with fitness and function in older adults: a cross-sectional latent profile analysis.

European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity·2026
Same author

[Correction to the Article "Pediatric Sarcopenia: What do We Know?"]

Acta medica portuguesa·2025
Same author

Editorial: Bone health and development in children and adolescents, volume II.

Frontiers in endocrinology·2025
Same author

Powerpenia: moving towards the detection of meaningful human 'skeletal muscle' power loss.

British journal of sports medicine·2025
Same journal

[Presence of Dermatologists on Social Media: Perception of the Portuguese Population].

Acta medica portuguesa·2026
Same journal

[Sexual Health in Oncology Patients and Cancer Survivors: A Structured Protocol to Address an Unmet Clinical Need at IPO-Porto].

Acta medica portuguesa·2026
Same journal

Hyperthermia in a Teenager: Is it Just a Heat Stroke?

Acta medica portuguesa·2026
Same journal

Cutaneous Polyarteritis Nodosa as the Inaugural Manifestation of Hairy Cell Leukemia.

Acta medica portuguesa·2026
Same journal

Alopecia Neoplastica from Breast Carcinoma: When Hair Loss Hides Something Else.

Acta medica portuguesa·2026
Same journal

[Burnout Among Residents: A Current Perspective].

Acta medica portuguesa·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.1K

Pediatric Sarcopenia: What do We Know?

Marília Marques1, Fátima Baptista2

  • 1Hospital Lusíadas Lisboa. Lisboa. & Departamento de Desporto e Saúde. Centro Interdisciplinar de Performance Humana (CIPER). Faculdade de Motricidade Humana. Universidade de Lisboa. Lisboa. Portugal.

Acta Medica Portuguesa
|October 17, 2025
PubMed
Summary
This summary is machine-generated.

Pediatric sarcopenia, a loss of muscle in children, impacts growth and raises risks for metabolic and cardiovascular diseases. Early detection and intervention through lifestyle changes and new therapies are vital for better child health outcomes.

Keywords:
ChildSarcopenia/diagnosisSarcopenia/etiologySarcopenia/prevention and control

More Related Videos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.6K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.1K
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.6K
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.7K

Area of Science:

  • Pediatric Health
  • Muscle Physiology
  • Developmental Pediatrics

Background:

  • Pediatric sarcopenia, initially associated with aging, is increasingly recognized in children and adolescents, especially those with chronic conditions.
  • This condition negatively impacts growth, neurodevelopment, and increases the risk of long-term metabolic and cardiovascular diseases.
  • Contributing factors include poor prenatal nutrition, low birth weight, genetics, inadequate protein intake, sedentary lifestyles, obesity, and chronic illnesses.

Purpose of the Study:

  • To review the current understanding of pediatric sarcopenia, including its causes, consequences, diagnostic challenges, and emerging therapeutic strategies.
  • To highlight the importance of early detection and intervention for improving pediatric health outcomes.

Main Methods:

  • Review of existing literature on pediatric sarcopenia, encompassing etiological factors, clinical manifestations, diagnostic limitations, and treatment advancements.
  • Analysis of current assessment tools and their shortcomings in pediatric populations.
  • Exploration of novel therapeutic avenues, including targeted drug delivery, regenerative medicine, and pharmacological interventions.

Main Results:

  • Reduced muscle mass in children leads to impaired bone health, delayed growth, and diminished physical performance, affecting quality of life.
  • Sarcopenia complicates clinical outcomes in chronically ill children, prolonging hospital stays and increasing complication rates.
  • Current diagnostic methods lack standardized pediatric reference values, hindering early detection.

Conclusions:

  • Pediatric sarcopenia presents significant short- and long-term health risks, necessitating focused attention.
  • Preventive measures include promoting physical activity, balanced nutrition, and healthy lifestyle habits.
  • While innovative treatments are emerging, pediatric-specific therapeutic guidelines are still undefined, emphasizing the need for further research and early intervention.